Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.
Buyside Digest is not affiliated with, and does not endorse, Emerald Wealth Partners - Focused Equity Strategy. This analysis is provided for institutional research purposes only and is not investment advice.
SOURCE UNAVAILABLE
Fund Returns
QTD+0.7%
YTD-3.1%
Annualized+13.9%
Positioning StanceCAUTIOUS
Market CapLarge Cap
GeographyGlobal
Digest Analysis
Quick Take
"Emerald underperformed in Q2 by avoiding the speculative semiconductor rally driving benchmarks, instead adding to high-quality compounders at rare valuations. With the US market's CAPE near 40 and bubble dynamics evident, the manager trimmed geopolitical winners (Shell, Lockheed) and added to AI enablers (Broadcom, ServiceNow) and mispriced Chinese franchises (Tencent, H World)."
Executive Summary
Emerald's Focused Equity Strategy returned 0.7% net in Q2 2026, underperforming a benchmark driven by speculative semiconductor momentum the manager deliberately avoided. The market exhibits late-cycle bubble characteristics: the US CAPE ratio stands near 40 (exceeded only at the dot-com peak), risk-taking is accelerating, and capital chases recent performance rather than fundamentals. Semiconductor indices have doubled since April as the market capitalizes cyclical peak earnings as durable, while the SpaceX IPO at $2 trillion valuation exemplifies FOMO-driven decision-making. The manager trimmed Shell and Lockheed Martin after strong Q1 gains compressed margins of safety, while adding to Chinese positions (Tencent, H World) brought to under 14x earnings, Broadcom following the OpenAI chip design win, and ServiceNow as an AI monetization vehicle rather than casualty. The portfolio's bottom-up expected return sits comfortably in double digits, driven by high-quality compounders now available at multi-decade low valuation spreads versus the broader market. The manager views this as an unusually attractive entry point for patient capital focused on long-term wealth creation through owning exceptional franchises at reasonable prices.
Unlock Full Institutional Analysis
Sign in or create a free account to unlock full commentary, extracted equity pitches, and direct outbound manager source links with your 3 quarterly credits.